Diagnosis of hypogonadism in ageing men

被引:8
作者
Kaufman, Jean-Marc [1 ]
机构
[1] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium
关键词
Hypogonadism; Ageing; Testosterone assay; Free testosterone; LATE-ONSET HYPOGONADISM; MASS-SPECTROMETRY; TESTOSTERONE LEVELS; OLDER MEN; ANDROGEN DEFICIENCY; SERUM TESTOSTERONE; LUTEINIZING-HORMONE; REFERENCE RANGES; YOUNG MEN; IMMUNOASSAY;
D O I
10.1007/s11154-022-09763-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To make the diagnosis of hypogonadism in an ageing man, in absence of rare organic cause often referred to as functional or late onset hypogonadism (LOH), he should present with a clinical syndrome suggestive of androgen deficiency and have consistently low serum testosterone (T) levels. This does not differ from the diagnosis of any other form of hypogonadism. Particular to LOH diagnostic are uncertainties surrounding this entity: signs and symptoms of androgen deficiency (including sexual symptoms) are nonspecific in older men; clinical significance of only moderately low T levels is uncertain; comorbidity plays a substantial role with potential for reversibility; the place of T therapy in these men is debatable. This context demands for a pragmatic, but appropriately conservative approach to diagnosis. Evaluation should be stepwise with clinical evaluation, if suggestive for androgen deficiency, followed by measurement of a fasting morning serum T, if unequivocally low to be confirmed in a separate morning sample by a second low T or, if initial T borderline low or in presence of factors known to affect SHBG, by a low calculated free T level. All other (free) T results make hypogonadism an unlikely cause of the patient's symptoms. In the absence of consensus cut-off levels for total and free T in the published clinical guidelines for diagnosis of hypogonadism, it seems appropriate in the context of LOH to use stringent criteria indicating a convincingly low serum T. The approach to the diagnosis of LOH is not fundamentally different from that of other forms of hypogonadism but should put extra weight on prioritizing the shunning of overdiagnosis above the risk of underdiagnosis.
引用
收藏
页码:1139 / 1150
页数:12
相关论文
共 50 条
  • [41] Importance of total and measured free testosterone in diagnosis of male hypogonadism: immunoassay versus mass spectrometry in a population of healthy young/middle-aged blood donors
    Agretti, P.
    Pelosini, C.
    Bianchi, L.
    Del Grosso, A.
    Saba, A.
    Canale, D.
    Sessa, M. R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (02) : 321 - 326
  • [42] Symptoms of Late-Onset Hypogonadism in Men
    Snyder, Peter J.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (04) : 755 - 760
  • [43] Hypogonadism Risk in Men Treated for Childhood Cancer
    Romerius, Patrik
    Stahl, Olof
    Moell, Christian
    Relander, Thomas
    Cavallin-Stahl, Eva
    Wiebe, Thomas
    Giwercman, Yvonne Lundberg
    Giwercman, Aleksander
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (11) : 4180 - 4186
  • [44] Male Hypogonadism: The Korean Society of Men's Health and Aging Position Statement
    Ahn, Sun Tae
    Kim, Young-Sang
    Yu, Sung Hoon
    Chung, Yoon-Sok
    WORLD JOURNAL OF MENS HEALTH, 2025,
  • [45] Subclinical male hypogonadism
    Corona, Giovanni
    Rastrelli, Giulia
    Dicuio, Mauro
    Concetti, Sergio
    Minnetti, Marianna
    Pivonello, Rosario
    Isidori, Andrea
    Sforza, Alessandra
    Maggi, Mario
    MINERVA ENDOCRINOLOGY, 2021, 46 (03): : 252 - 261
  • [46] Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men
    Corona, Giovanni
    Bianchini, Silvia
    Sforza, Alessandra
    Vignozzi, Linda
    Maggi, Mario
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 14 (04): : 569 - 578
  • [47] Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy
    Lachatre, Marie
    Pasquet, Armelle
    Ajana, Faiza
    Soudan, Benoit
    Quertainmont, Yann
    Lion, Georges
    Durand, Emmanuel
    Bocket, Laurence
    Mole, Martine
    Cornavin, Pauline
    Catalan, Pilartxo
    Senneville, Eric
    Goujard, Cecile
    Boufassa, Faroudy
    Cheret, Antoine
    AIDS, 2022, 36 (08) : 1061 - 1071
  • [48] Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study
    Shigehara, Kazuyoshi
    Koh, Eitetsu
    Sakamoto, Jiro
    Yaegashi, Hiroshi
    Izumi, Koji
    Ueno, Satoru
    Kitagawa, Yasuhide
    Maeda, Yuji
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Nakashima, Takao
    Namiki, Mikio
    AGING MALE, 2014, 17 (01) : 51 - 56
  • [49] Obesity, type 2 diabetes, and testosterone in ageing men
    Wittert, Gary
    Grossmann, Mathis
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2022, 23 (06) : 1233 - 1242
  • [50] Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men
    Wu, Frederick C. W.
    Tajar, Abdelouahid
    Beynon, Jennifer M.
    Pye, Stephen R.
    Silman, Alan J.
    Finn, Joseph D.
    O'Neill, Terence W.
    Bartfai, Gyorgy
    Casanueva, Felipe F.
    Forti, Gianni
    Giwercman, Aleksander
    Han, Thang S.
    Kula, Krzysztof
    Lean, Michael E. J.
    Pendleton, Neil
    Punab, Margus
    Boonen, Steven
    Vanderschueren, Dirk
    Labrie, Fernand
    Huhtaniemi, Ilpo T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02) : 123 - 135